These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 26122834)

  • 1. Clinical Safety and Preliminary Efficacy of Plasmid pUDK-HGF Expressing Human Hepatocyte Growth Factor (HGF) in Patients with Critical Limb Ischemia.
    Cui S; Guo L; Li X; Gu Y; Fu J; Dong L; Song H; Chen X; Lu Y; Hu C; Xiao F; Zhu D; Wu Z; Zhang Q
    Eur J Vasc Endovasc Surg; 2015 Oct; 50(4):494-501. PubMed ID: 26122834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase I clinical study of naked DNA expressing two isoforms of hepatocyte growth factor to treat patients with critical limb ischemia.
    Gu Y; Zhang J; Guo L; Cui S; Li X; Ding D; Kim JM; Ho SH; Hahn W; Kim S
    J Gene Med; 2011 Nov; 13(11):602-10. PubMed ID: 22015632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia.
    Powell RJ; Simons M; Mendelsohn FO; Daniel G; Henry TD; Koga M; Morishita R; Annex BH
    Circulation; 2008 Jul; 118(1):58-65. PubMed ID: 18559703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Critical Limb Ischemia by pIRES/VEGF165/HGF Administration.
    Barć P; Antkiewicz M; Śliwa B; Baczyńska D; Witkiewicz W; Skóra JP
    Ann Vasc Surg; 2019 Oct; 60():346-354. PubMed ID: 31200059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I/IIa clinical trial of therapeutic angiogenesis using hepatocyte growth factor gene transfer to treat critical limb ischemia.
    Morishita R; Makino H; Aoki M; Hashiya N; Yamasaki K; Azuma J; Taniyama Y; Sawa Y; Kaneda Y; Ogihara T
    Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):713-20. PubMed ID: 21183732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pUDK-HGF Gene Therapy to Relieve CLI Rest Pain and Ulcer: A Phase II, Double-Blind, Randomized Placebo-Controlled Trial.
    Gu Y; Cui S; Liu C; Zhao J; Li M; Li Y; Yang X; Lv B; Li M; Zhao W; Guo W; Huang J; Huang W; Qiu Z; Zhao J; Yin P; Qin T; Zhu D; Sun W; Ren K; Lu Y; Cheng X; Du L; Xiao F; Zhang Q; Wu Z
    Hum Gene Ther; 2021 Aug; 32(15-16):839-849. PubMed ID: 33726499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of a non-viral plasmid-encoding dual isoforms of hepatocyte growth factor in critical limb ischemia patients: a phase I study.
    Henry TD; Hirsch AT; Goldman J; Wang YL; Lips DL; McMillan WD; Duval S; Biggs TA; Keo HH
    Gene Ther; 2011 Aug; 18(8):788-94. PubMed ID: 21430785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease.
    Morishita R; Aoki M; Hashiya N; Makino H; Yamasaki K; Azuma J; Sawa Y; Matsuda H; Kaneda Y; Ogihara T
    Hypertension; 2004 Aug; 44(2):203-9. PubMed ID: 15238569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of patient specific intramuscular injection of HGF plasmid gene therapy on limb perfusion and wound healing in patients with ischemic lower extremity ulceration: results of the HGF-0205 trial.
    Powell RJ; Goodney P; Mendelsohn FO; Moen EK; Annex BH;
    J Vasc Surg; 2010 Dec; 52(6):1525-30. PubMed ID: 21146749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of 5-year follow-up study in patients with peripheral artery disease treated with PL-VEGF165 for intermittent claudication.
    Deev R; Plaksa I; Bozo I; Mzhavanadze N; Suchkov I; Chervyakov Y; Staroverov I; Kalinin R; Isaev A
    Ther Adv Cardiovasc Dis; 2018 Sep; 12(9):237-246. PubMed ID: 29996720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined Analysis of Clinical Data on HGF Gene Therapy to Treat Critical Limb Ischemia in Japan.
    Morishita R; Shimamura M; Takeya Y; Nakagami H; Chujo M; Ishihama T; Yamada E; Rakugi H
    Curr Gene Ther; 2020; 20(1):25-35. PubMed ID: 32416690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfection of human HGF plasmid DNA improves limb salvage in Buerger's disease patients with critical limb ischemia.
    Shigematsu H; Yasuda K; Sasajima T; Takano T; Miyata T; Ohta T; Tanemoto K; Obitsu Y; Iwai T; Ozaki S; Ogihara T; Morishita R;
    Int Angiol; 2011 Apr; 30(2):140-9. PubMed ID: 21427651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gram-scale production of plasmid pUDK-HGF with current good manufacturing practices for gene therapy of critical limb ischemia.
    Hu C; Cheng X; Lu Y; Wu Z; Zhang Q
    Prep Biochem Biotechnol; 2016 Nov; 46(8):844-849. PubMed ID: 26853514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of High-pressure, Intermittent Pneumatic Compression for the Treatment of Peripheral Arterial Disease and Critical Limb Ischemia in Patients Without a Surgical Option.
    Alvarez OM; Wendelken ME; Markowitz L; Comfort C
    Wounds; 2015 Nov; 27(11):293-301. PubMed ID: 26574751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale and design of the MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia in Subjects with Severe Peripheral Arterial Disease (MOBILE) trial investigating autologous bone marrow cell therapy for critical limb ischemia.
    Wang SK; Green LA; Motaganahalli RL; Wilson MG; Fajardo A; Murphy MP
    J Vasc Surg; 2017 Jun; 65(6):1850-1857.e2. PubMed ID: 28390770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Hepatocyte Growth Factor in the Treatment of Critical Limb Ischemia.
    Gu Y; Cui S; Wang Q; Liu C; Jin B; Guo W; Liu C; Chu T; Shu C; Zhang F; Han C; Liu Y
    Mol Ther; 2019 Dec; 27(12):2158-2165. PubMed ID: 31805256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic Assessment Before and After Endovascular Therapy for Critical Limb Ischemia and Association With Clinical Outcomes.
    Reed GW; Young L; Bagh I; Maier M; Shishehbor MH
    JACC Cardiovasc Interv; 2017 Dec; 10(23):2451-2457. PubMed ID: 29153498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of autologous transplantation of G-CSF-mobilized peripheral blood mononuclear cells and Panax notoginseng saponins in the treatment of unreconstructable critical limb ischemia.
    Wang X; Jiang L; Wang X; Yin F; Li G; Feng X; Wang K; Sun S
    Ann Vasc Surg; 2014 Aug; 28(6):1501-12. PubMed ID: 24632316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, double-blind, placebo-controlled clinical trial of hepatocyte growth factor plasmid for critical limb ischemia.
    Shigematsu H; Yasuda K; Iwai T; Sasajima T; Ishimaru S; Ohashi Y; Yamaguchi T; Ogihara T; Morishita R
    Gene Ther; 2010 Sep; 17(9):1152-61. PubMed ID: 20393508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of sustained release of basic fibroblast growth factor using gelatin hydrogel in patients with critical limb ischemia.
    Kumagai M; Marui A; Tabata Y; Takeda T; Yamamoto M; Yonezawa A; Tanaka S; Yanagi S; Ito-Ihara T; Ikeda T; Murayama T; Teramukai S; Katsura T; Matsubara K; Kawakami K; Yokode M; Shimizu A; Sakata R
    Heart Vessels; 2016 May; 31(5):713-21. PubMed ID: 25861983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.